Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/21 → 11/30/23 |
Funding
- ImmunoChem Therapeutics, LLC (SP0064289 AMD 2 // 1R44AG071062-01A1)
- National Institute on Aging (SP0064289 AMD 2 // 1R44AG071062-01A1)
Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk
- Kearney, Jennifer A (PD/PI)
Project: Research project